Literature DB >> 15947066

Lessons from the bone marrow: how malignant glioma cells attract adult haematopoietic progenitor cells.

Ghazaleh Tabatabai1, Oliver Bähr, Robert Möhle, Ilker Y Eyüpoglu, Andreas M Boehmler, Jörg Wischhusen, Johannes Rieger, Ingmar Blümcke, Michael Weller, Wolfgang Wick.   

Abstract

Stem and progenitor cells (PCs) of various lineages have become attractive vehicles to improve therapeutic gene delivery to cancers, notably glioblastoma. Here we report that adult human and murine haematopoietic PCs display a tropism for intracerebral gliomas but not for normal brain tissue in mice. Organotypic hippocampal slice culture and spheroid confrontation assays confirm a directed PC migration towards glioma cells ex vivo and in vitro. RNA interference-mediated disruption of transforming growth factor beta (TGF-beta) synthesis by the glioma cells strongly inhibits PC migration. We delineate a CXC chemokine ligand (CXCL) 12-dependent pathway of TGF-beta-induced PC migration that is facilitated by MMP-9-mediated stem cell factor cleavage in vitro. Moreover, neutralizing antibodies to CXCL12 strongly reduce PC homing to experimental gliomas in vivo. Thus, we define here the molecular mechanism underlying the glioma tropism of the probably most easily accessible PC population suitable for cancer therapy, that is, adult haematopoietic PC.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15947066     DOI: 10.1093/brain/awh563

Source DB:  PubMed          Journal:  Brain        ISSN: 0006-8950            Impact factor:   13.501


  22 in total

1.  Use of genetically engineered stem cells for glioma therapy.

Authors:  Hiroki Namba; Hiroshi Kawaji; Tomohiro Yamasaki
Journal:  Oncol Lett       Date:  2015-11-04       Impact factor: 2.967

2.  Monitoring the glioma tropism of bone marrow-derived progenitor cells by 2-photon laser scanning microscopy and positron emission tomography.

Authors:  Kathy Hasenbach; Stefan Wiehr; Caroline Herrmann; Julia Mannheim; Funda Cay; Gabriele von Kürthy; Tristan Bolmont; Stefan A Grathwohl; Michael Weller; Claudia Lengerke; Bernd J Pichler; Ghazaleh Tabatabai
Journal:  Neuro Oncol       Date:  2012-02-01       Impact factor: 12.300

3.  The homing of human cord blood stem cells to sites of inflammation: unfolding mysteries of a novel therapeutic paradigm for glioblastoma multiforme.

Authors:  Kiran Kumar Velpula; Venkata Ramesh Dasari; Jasti S Rao
Journal:  Cell Cycle       Date:  2012-06-15       Impact factor: 4.534

4.  Specific chemotaxis of magnetically labeled mesenchymal stem cells: implications for MRI of glioma.

Authors:  Margaret F Bennewitz; Kevin S Tang; Eleni A Markakis; Erik M Shapiro
Journal:  Mol Imaging Biol       Date:  2012-12       Impact factor: 3.488

Review 5.  Toward brain tumor gene therapy using multipotent mesenchymal stromal cell vectors.

Authors:  Daniel Bexell; Stefan Scheding; Johan Bengzon
Journal:  Mol Ther       Date:  2010-04-20       Impact factor: 11.454

Review 6.  Concise review: Nanoparticles and cellular carriers-allies in cancer imaging and cellular gene therapy?

Authors:  Catherine Tang; Pamela J Russell; Rosetta Martiniello-Wilks; John E J Rasko; Aparajita Khatri
Journal:  Stem Cells       Date:  2010-09       Impact factor: 6.277

Review 7.  Stem cells tropism for malignant gliomas.

Authors:  Feng Xu; Jian-Hong Zhu
Journal:  Neurosci Bull       Date:  2007-11       Impact factor: 5.203

8.  Survival and Proliferation of Neural Progenitor-Derived Glioblastomas Under Hypoxic Stress is Controlled by a CXCL12/CXCR4 Autocrine-Positive Feedback Mechanism.

Authors:  Anda-Alexandra Calinescu; Viveka Nand Yadav; Erica Carballo; Padma Kadiyala; Dustin Tran; Daniel B Zamler; Robert Doherty; Maithreyi Srikanth; Pedro Ricardo Lowenstein; Maria Graciela Castro
Journal:  Clin Cancer Res       Date:  2016-08-19       Impact factor: 12.531

Review 9.  Cytokines: shifting the balance between glioma cells and tumor microenvironment after irradiation.

Authors:  Wei Zhou; Zheng Jiang; Xingang Li; Yangyang Xu; Zhenyu Shao
Journal:  J Cancer Res Clin Oncol       Date:  2014-07-09       Impact factor: 4.553

Review 10.  Recent progress in the research of suicide gene therapy for malignant glioma.

Authors:  Ryota Tamura; Hiroyuki Miyoshi; Kazunari Yoshida; Hideyuki Okano; Masahiro Toda
Journal:  Neurosurg Rev       Date:  2019-11-28       Impact factor: 3.042

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.